Induced Pluripotent Stem Cell Technology and Direct Conversion: New Possibilities to Study and Treat Parkinson’s Disease

Recent developments in in vitro disease modeling and regenerative medicine have placed induced pluripotent stem cells (iPSCs) in the center of attention as a unique source to study Parkinson’s disease. After only 5 years of intensive research, human iPSCs can be generated without viral integration a...

Descripción completa

Detalles Bibliográficos
Autores principales: Roessler, Reinhard, Boddeke, Erik, Copray, Sjef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742952/
https://www.ncbi.nlm.nih.gov/pubmed/22529017
http://dx.doi.org/10.1007/s12015-012-9369-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742952/
https://www.ncbi.nlm.nih.gov/pubmed/22529017
http://dx.doi.org/10.1007/s12015-012-9369-4

Ejemplares similares